CompletedNot Applicable

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

United States240 participantsStarted 2020-09-29

Plain-language summary

The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.

Who can participate

Age range35 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Breast Cancer group * Female sex * Between ages of 35-55 * No previous diagnosis of breast cancer Colon Cancer Group * Between ages of 45-75 * No previous diagnosis of colon cancer Prostate Cancer Group * Male sex * Between ages of 45-74 * No previous diagnosis of prostate cancer Lung Cancer Group * Between ages of 50-80 * No previous diagnosis of lung cancer Exclusion Criteria: Breast Cancer group * Unable to confirm primary language is English * History of breast cancer * Severe cognitive impairment who cannot consent for themselves Colon Cancer Group * Unable to confirm primary language is English * History of colon cancer * Severe cognitive impairment who cannot consent for themselves Prostate Cancer Group * Unable to confirm primary language is English * History of prostate cancer * Severe cognitive impairment who cannot consent for themselves Lung Cancer Group * Unable to confirm primary language is English * History of lung cancer * Severe cognitive impairment who cannot consent for themselves

What they're measuring

Shared Decision Making Process Measure

Timeframe: Baseline survey

Trial details

NCT IDNCT04601272

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-16

Results submitted2022-03-04

View on ClinicalTrials.gov More Breast Cancer Screening trials

Who can participate

Age range35 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.